Source comparison
Biological vs Functional Half Life: Why Plasma Clearance Doesn't Tell the Whole Story
The 70–90 minute hexarelin half life refers to plasma elimination—the time required for serum concentrations to decline by 50%. But functional half life—the duration during which the peptide exerts meaningful biological activity—is often shorter. This distinct
This comparison does not assign a generated winner or score.
- The 70–90 minute hexarelin half life refers to plasma elimination—the time required for serum concentrations to decline by 50%. But functional half life—the duration during which the peptide exerts meaningful biological activity—is often shorter. This distinction matters because hexarelin's effects depend not just on its presence in circulation, but on its ability to maintain receptor occupancy at concentrations high enough to trigger downstream signaling cascades.
- GHS-R1a receptors exhibit high constitutive activity—they generate baseline signaling even without ligand binding—but hexarelin must reach a threshold concentration to shift the receptor into its fully active conformation and trigger maximal GH secretion. Studies using dynamic receptor occupancy modeling estimate that hexarelin's functional half life (the time during which receptor activation remains above 50% of peak) is approximately 45–60 minutes, significantly shorter than its plasma half life. By 90 minutes post-injection, receptor occupancy has dropped to less than 30% of peak levels, and GH secretion has returned to near-baseline despite detectable hexarelin remaining in serum.
- This disconnect explains why some researchers report "hexarelin stopped working" after several weeks—they're likely experiencing receptor desensitization rather than true compound failure. Chronic or high-frequency hexarelin administration downregulates GHS-R1a receptor expression in the pituitary, a well-documented phenomenon in rodent models and human studies. A 1999 trial published in the Journal of Endocrinological Investigation found that daily 100 mcg hexarelin administration for 16 weeks reduced the GH response to subsequent hexarelin challenge by approximately 35% compared to baseline, even though plasma hexarelin concentrations remained unchanged. The mechanism involves receptor internalization and reduced surface expression—essentially, the pituitary becomes less sensitive to the same plasma concentration.
- Cycling protocols mitigate this. Most experienced researchers administer hexarelin for 8–12 weeks followed by a 4–6 week washout period, allowing receptor expression to recover. During the washout, plasma hexarelin clears completely within 12 hours due to the short half life, but receptor upregulation takes weeks because it involves transcriptional regulation and protein synthesis. The functional implication: hexarelin's short half life means you can clear the compound from your system rapidly when cycling off, but you cannot rush receptor recovery by simply waiting a few days.